DelRicht Research
Welcome,         Profile    Billing    Logout  
 6 Trials 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hordinsky, Maria
NCT03651752: DPCP for the Treatment of Alopecia Areata

Completed
3
10
US
Diphenylcyclopropenone (DPCP) Ointment
University of Minnesota, National Alopecia Areata Foundation
Alopecia Areata
09/24
09/24
SCALP1, NCT05910450: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

Recruiting
3
726
US, RoW
Clascoterone 5% solution, CB-03-01 5% solution, Vehicle solution, Vehicle
Cassiopea SpA, Ergomed PLC, Pharmapace Inc, Canfield Scientific Inc., ICON Clinical Research
Alopecia, Androgenetic
10/24
04/25
BRAVE-AA-PEDS, NCT05723198: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

Recruiting
3
595
Europe, Canada, Japan, US, RoW
Baricitinib, LY3009104, Placebo
Eli Lilly and Company
Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical
09/24
08/29
BRAVE-AA1, NCT03570749: A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

Checkmark Efficacy and safety data from BRAVE-AA1 trial in adults with severe alopecia areata
Apr 2021 - Apr 2021: Efficacy and safety data from BRAVE-AA1 trial in adults with severe alopecia areata
Checkmark From BRAVE-AA1 trial for alopecia areata
Oct 2020 - Oct 2020: From BRAVE-AA1 trial for alopecia areata
Active, not recruiting
2/3
824
Japan, US, RoW
Baricitinib, LY3009104, Placebo
Eli Lilly and Company, Incyte Corporation
Alopecia Areata
02/21
01/25
NCT05514834: BCT-HA Kit for Dehydrated and Wrinkled Skin

Completed
1
15
US
Cellular Matrix TM BCT-HA Kit (ref. BCT-HA-3), PRP Only, Placebo
University of Minnesota
Rhytides, Wrinkle
10/23
02/24
NCT00177073: Alopecia Areata Registry and Immunogenetic Mechanisms

Recruiting
N/A
2000
US
questionnaires, Alopecia areata universalis/totalis.
University of Minnesota - Clinical and Translational Science Institute, M.D. Anderson Cancer Center, Columbia University, University of Colorado, Denver, University of California
Alopecia Areata
12/13
12/14
NCT06357169: Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias

Terminated
N/A
1
US
Venus Glow
University of Minnesota
Lichen Planopilaris of Scalp, Alopecia Areata
06/23
01/24
NCT03335228: Platelet Rich Plasma for Frontal Fibrosing Alopecia

Not yet recruiting
N/A
20
US
Eclipse Easy Spin for PRP
University of Minnesota
Frontal Fibrosing Alopecia
09/25
09/26
NCT05319444: Cleansing Device for the Treatment of Scalp and Hair Conditions

Recruiting
N/A
40
US
Off-brand Waterpik®
University of Minnesota
Dandruff, Seborrheic Dermatitis, Hair Loss
11/25
11/25
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting
N/A
15000
Europe, Canada, US
Target PharmaSolutions, Inc.
Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria
12/50
12/50

Download Options